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Abstract
Background: Evidence-based comparison of the disorder-specific welfare burdens of major canine conditions
could better inform targeting of stakeholder resources, to maximise improvement of health-related welfare in UK
dogs. Population-level disease related welfare impact offers a quantitative, welfare-centred framework for objective
disorder prioritisation, but practical applications have been limited to date due to sparse reliable evidence on
disorder-specific prevalence, severity and duration across the canine disease spectrum. The VetCompass™
Programme collects de-identified electronic health record data from dogs attending primary-care clinics UK-wide,
and is well placed to fill these information gaps.
Results: The eight common, breed-related conditions assessed were anal sac disorder, conjunctivitis, dental disease,
dermatitis, overweight/obese, lipoma, osteoarthritis and otitis externa. Annual period prevalence estimates (based on
confirming 250 cases from total potential cases identified from denominator population of 455, 557 dogs) were
highest for dental disorder (9.6%), overweight/obese (5.7%) and anal sac disorder (4.5%). Dental disorder (76%
of study year), osteoarthritis (82%), and overweight/obese (70%) had highest annual duration scores. Osteoarthritis
(scoring 13/21), otitis externa (11/21) and dermatitis demonstrated (10/21) highest overall severity scores. Dental
disorder (2.47/3.00 summative score), osteoarthritis (2.24/3.00) and overweight/obese (1.67/3.00) had highest
VetCompass Welfare Impact scores overall.
Discussion: Of the eight common, breed-related disorders assessed, dental disorder, osteoarthritis and overweight/
obese demonstrated particular welfare impact, based on combinations of high prevalence, duration and severity.
Future work could extend this methodology to cover a wider range of disorders.
Conclusions: Dental disorders, osteoarthritis and overweight/obese have emerged as priority areas for health-
related welfare improvement in the UK dog population. This study demonstrated applicability of a standardised
methodology to assess the relative health-related welfare impact across a range of canine disorders using VetCompass
clinical data.
Keywords: Canine, Welfare, Evidence-based, Breed-related, Prioritisation, Duration, Severity, Prevalence, VetCompass,
EHR, EPR
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Background
Breed-related disorders in dogs have been documented,
discussed and investigated for well over a century [1–6]
and concerns surrounding their negative effects on UK
pedigree dog welfare are well established [7, 8]. Despite
high profile media exposure and campaigns promoting
public awareness of health issues, the popularity of pure-
bred dogs as pets continues, with rising demand for cer-
tain ‘fashionable’ breeds regardless of well documented
predispositions for particular health problems (e.g. pugs,
French bulldogs) [9–13]. Recent independent inquiries
called for further research and coordinated action to re-
duce the welfare burden of breed-related conditions on
the pedigree dog population as a whole [5, 8, 14] and
some progress has been made [15–17]. However, ration-
ally identifying which of reportedly hundreds of breed-
linked disorders should be prioritised to achieve greatest
overall improvement in pedigree dog welfare from avail-
able resources remains a challenge [14, 18, 19]. This
issue is even more complex when broadening the defin-
ition of ‘breed-associated’ disorders beyond those with
evidence for direct genetic inheritance – it may be that
certain conditions which could and do occur in any
breed are far more likely in particular canine breeds or
types, for epigenetic or owner-related environmental and
socioeconomic reasons. In practical welfare terms, such
conditions could also be considered ‘breed-associated’ to
some degree, even if not strictly heritable or breed-
exclusive.
Canine welfare is a dynamic discipline, with standards
and definitions constantly evolving alongside ongoing
animal welfare research [20–23]. There is apparent con-
sensus between animal welfare scientists, canine welfare
organisations and within UK legislation that health
(incorporating, but not limited to, physical pain) is one
of the most important elements contributing to the wel-
fare of individual animals [24–27]. However, individual
stakeholder opinions vary widely regarding the relative
importance of specific areas of canine health-related
welfare concern [28–32]. Evidence-based approaches to
prioritising disorders for research and resource alloca-
tion are established in human medicine [33, 34] but
there is currently no formal veterinary equivalent. A
transparent, evidence-based strategy to identify, quantify
and compare population-level welfare burdens of key ca-
nine conditions is required. Applied in a standardised
way, outcomes of this objective comparison tool could
inform strategic targeting of available stakeholder re-
sources, optimising overall canine health-related welfare
improvement [35, 36].
Emerging concepts/tools in animal welfare epidemi-
ology now offer an ethically and scientifically sound con-
ceptual framework for disorder comparison according to
relative health-related welfare impact at the population
level [35, 36]. Historically, canine welfare assessment
scales proposed were disorder-specific and applicable at
individual dog, rather than population, level [37–41].
Efforts to address this within the animal welfare science
community are progressing, with development of met-
rics designed to quantify and compare detrimental wel-
fare effects across a range of canine disorders, taking
into account various aspects of welfare impairment.
Examples include the Generic Illness Severity Index for
Dogs (GISID; a measure of relative severity for canine
inherited diseases) [14], Breed-Disorder Welfare Impact
Score (BDWIS; a measure of welfare impact on dogs
with particular inherited diseases) [36] and more re-
cently, Welfare-Adjusted Life Years (WALYs) [42].
Welfare impact assessment takes into account measures
of disorder prevalence, severity and duration to report
and compare the welfare importance of individual disor-
ders for a given population, providing a quantitative,
welfare-centric basis for objective disorder prioritisation
[35]. Practical applications of this approach are estab-
lished in production and laboratory animal welfare scor-
ing systems [43, 44]. To date, suggested application of
the concept to pet dog populations has been limited by
a dearth of reliable, disorder-specific evidence on preva-
lence, duration and severity of effect of specific condi-
tions in different breeds [14, 18, 35, 36]. Furthermore,
large-scale datasets relevant to pet dog health have been
unavailable due to commercial sensitivity, or else impos-
sible to interrogate using existing validated tools. The
VetCompass animal health surveillance programme
holds clinical electronic health record (EHR) data from
over 5 million dogs attending over 1000 primary-care
clinics UK-wide, and is well placed to fill information
gaps relevant to disorder-specific welfare impact using
clinical and demographic information that is both
large-scale and geographically representative [45].
Aims and objectives
This project aimed to provide an evidence-led basis for
prioritising action on certain canine breed-related disor-
ders over others, according to comparative health-re-
lated welfare impact. Broadly, the objectives were to:
1. Develop a data-driven strategy for disorder prioritisation,
using novel welfare metrics to evaluate the data available
in routinely collected canine EHR.
2. Apply this strategy to a defined set of relevant disorders,
providing transparent evidence to support particular
disorders as priorities for reform.
Results
The eight disorders selected for assessment of relative
health-related welfare impact were anal sac disorder, con-
junctivitis, dental disorder, dermatitis, lipoma, osteoarthritis,
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otitis externa and overweight/obese. Disorder groupings
were based on previously published VetCompass analyses
estimating prevalence of disorders recorded in dogs attend-
ing primary-care veterinary practices in England [46]. The
denominator study population comprised 455,557 dogs
under the care of 304 VetCompass participating clinics dis-
tributed throughout the UK.
Health related welfare metrics
Annual period prevalence
All-breed annual period prevalence estimates with 95%
confidence intervals for the eight disorders assessed are
presented in Table 1. Dental disorder (9.6%), overweight/
obese (5.7%) and anal sac disorder (4.5%) had highest es-
timated prevalences for this annual period.
Duration
Otitis externa, anal sac disorder, conjunctivitis and
dermatitis all showed a median of one episode per case
over the year, with maximum annual episode counts
varying from three (conjunctivitis) to seven (anal sac dis-
order) (Table 2). Neither median annual number of epi-
sodes or median episode duration were calculated for
osteoarthritis on the assumption that, once present, this
disorder was continuously present until death (non-epi-
sodic) rather than intermittent/episodic. The proportion
of cases diagnosed with more than one episode during
the study year was thus reported as ‘Not applicable’ for
osteoarthritis. It was not possible to reliably calculate
median annual number of episodes or median episode
duration for dental disorder, overweight/obese or lipoma
groups as so few cases had sufficiently clear data avail-
able on both episode diagnosis and resolution dates. Pro-
portion of cases diagnosed with more than one episode
was reported as zero for these three disorders, as, des-
pite the biological plausibility of multiple episodes (e.g.
total removal and subsequent recurrence of lipoma, fluc-
tuation between obesity and healthy bodyweight) there
was insufficiently clear data available to confirm multiple
episodes in any case (Table 2).
For osteoarthritis, lipoma, dental disorder, overweight/
obese and conjunctivitis the proportion of cases affected
for the entire study period ranged from 39.9% (dental
disorder) to 1.2% (conjunctivitis, based on 3 cases diag-
nosed with keratoconjunctivitis sicca before 01.01.2013)
(Table 2). Across the eight disorders, the median annual
duration (median % of year affected) ranged from 81.9%
in the osteoarthritis group to 2.2% for conjunctivitis
cases (Table 2).
Median ages at earliest disorder-related visit during
the year for the eight conditions were 4.0 years for anal
sac disorder and conjunctivitis, 4.2 for dermatitis, 5.1 for
otitis externa, 5.2 for overweight/obese, 6.0 for dental
disease, 9.3 for lipoma and 9.9 years for osteoarthritis
(Table 2). Within-disorder interquartile range (IQR) for
this measure was widest for conjunctivitis (6.7 years) and
narrowest for lipoma (3.8 years). Data for this measure
were complete (i.e. available for all 250 study dogs) in
osteoarthritis, otitis externa and anal sac disorder case
groups, with lowest data availability in the dermatitis
group (245 dogs contributing data).
Severity
Table 3 presents individual metric and overall severity
scores for each disorder. Overall severity scores (max-
imum possible score of 21) were highest for osteoarth-
ritis (13/21 score), followed by otitis externa (11/21),
dermatitis (10/21), conjunctivitis (9/21), lipoma (8/21),
anal sac disorder and dental disorder (7/21) and over-
weight/obese (3/21).
VetCompass welfare impact score
As the highest scoring disorders assessed, dental dis-
order (prevalence 9.62%) and osteoarthritis (duration
81.9%; overall severity score 13/21) provided reference
values for calculation of relative prevalence, duration
and severity index scores across conditions. Dental dis-
order ranked highest for the VetCompass Welfare Im-
pact score (VWI score 2.47) followed by osteoarthritis
(2.24), overweight/obese (1.67), lipoma (1.41), otitis
externa (1.30), dermatitis (1.19), anal sac disorder (1.05)
and conjunctivitis (0.96) (Table 4).
Numerical over-representation of individual breeds within
disorder-specific study case groups
In each disorder a number of breeds showed numerical
over-representation as evidenced by breed-specific:all-breed
prevalence ratios greater than one, with a number of breeds
additionally demonstrating no overlap of 95% confidence
intervals for breed-specific and all-breed prevalence esti-
mates in each disorder other than for dermatitis (Table 1).
Prevalence ratios greater than two were seen for the follow-
ing breeds in the stated disorder study groups: Greyhound,
CKCS and Border terrier in dental disorder (ratios 5.2, 2.5,
2.0 respectively), Beagle and CKCS in overweight/obese
(3.1, 2.0), CKCS, Bulldog and Shih-tzu in anal sac disorder
(4.1, 3.2, 2.4), KCS, WHWT and Pug in otitis externa (4.2;
2.2; 2.1), Bulldog and Border terrier in dermatitis (3.2, 2.0),
Golden retriever, Labrador, Rottweiler and GSD in osteo-
arthritis (3.9, 2.8, 2.7, 2.5), CKCS in conjunctivitis (3.1),
Labrador, Springer spaniel and Golden retriever in lipoma
(2.6, 2.3, 2.0).
Discussion
Improving the health-related welfare of dogs requires
identification and prioritisation of important health is-
sues for targeted reform. Breed-related disorders are
established as a significant issue affecting UK dog
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Table 1 All-breed annual period prevalence estimates for eight common disorders of UK dogs with evidence for breed-related status
Disorder
assessed
All-breed annual
period prevalence
estimate (%)
[95% CI]
Breeds with numerical over-representation in disorder case group compared with background
VetCompass population
Breed/type N (of 250
study cases)
Breed-specific annual
period prevalence
estimate (%)
95% CI (%) Prevalence ratio
(Breed-specific
prevalence:All-breed
prevalence)
Dental disorder 9.6 [8.5–10.8] Greyhound 9 50.0 (26.8–73.0) 5.2
CKCS 14 24.2 (13.1–35.2) 2.5
Border terrier 6 19.3 (5.4–33.1) 2.0
Bichon 7 18.6 (6.2–31.0) 1.9
Chihuahua 11 16.4 (7.5–25.1) 1.7
Cocker spaniel 14 14.9 (7.7–22.1) 1.6
Springer spaniel 9 14.1 (5.6–22.6) 1.5
Yorkshire terrier 12 13.7 (6.5–20.8) 1.4
JRT 19 12.0 (7.0–17.1) 1.3
WHWT 8 11.7 (4.1–19.3) 1.2
Overweight / obesity 5.7 [5.0–6.4] Beagle 6 17.8 (4.9–30.7) 3.1
CKCS 11 11.3 (5.0–17.6) 2.0
Labrador 34 10.6 (7.2–14.0) 1.9
Pug 5 9.7 (1.6–17.7) 1.7
Golden retriever 5 9.6 (1.6–17.5) 1.7
Border terrier 5 9.5 (1.6–17.5) 1.7
Bichon 6 9.4 (2.3–16.6) 1.7
Cocker spaniel 14 8.9 (4.4–13.3) 1.6
JRT 22 8.3 (5.0–11.6) 1.5
WHWT 9 7.8 (2.9–12.7) 1.4
Springer spaniel 8 7.4 (2.5–12.4) 1.3
Anal sac disorder 4.5 [4.0–5.0] CKCS 23 18.7 (11.8–25.6) 4.1
Bulldog 6 14.6 (3.8–25.4) 3.2
Shih-tzu 20 11.0 (6.4–15.5) 2.4
Bichon 6 7.5 (1.7–13.2) 1.7
Cocker spaniel 13 6.8 (3.2–10.3) 1.5
Lhasa Apso 5 6.0 (0.9–11.1) 1.3
WHWT 8 5.5 (1.8–9.2) 1.2
Springer spaniel 7 5.2 (1.4–8.9) 1.1
Otitis externa 4.0 [3.5–4.5] KCS 5 16.6 (3.3–29.9) 4.2
WHWT 15 8.6 (4.5–12.8) 2.2
Pug 5 8.1 (1.3–14.9) 2.1
Cocker Spaniel 17 6.6 (3.6–9.7) 1.7
Labrador 35 6.0 (4.1–8.0) 1.5
Springer Spaniel 8 6.0 (2.0–10.0) 1.5
GSD 11 5.6 (2.4–8.8) 1.4
CKCS 7 5.0 (1.4–8.5) 1.3
Dermatitis 3.6 [3.1–4.0] Bulldog 6 11.5 (2.9–20.2) 3.2
Border terrier 6 7.2 (1.6–12.7) 2.0
Bichon 7 6.9 (2.0 - 11.8) 1.9
GSD 13 6.7 (3.2–10.3) 1.9
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welfare, but identifying specific disorders on which to
focus available resources for maximum canine welfare
improvement is challenging [8, 14, 18]. This paper de-
scribes the development and application of a VetCom-
pass data-driven strategy for evidence-based canine
disorder prioritisation based on comparing relative
health-related welfare impact. Novel welfare metrics, de-
veloped to assess annual frequency, severity and dur-
ation across disorders, were generated for eight major
disorders with evidence of breed associations, using
EHR data from randomly selected cases identified from
VetCompass. Comparable, group-level disorder preva-
lence, severity and duration scores were combined into
novel VetCompass Welfare Impact scores, reflecting
relative disorder-specific, population-level welfare impact
and highlighting areas of particular welfare concern for
potential targeted reform [35, 36]. The described
methods for data-driven, health-related welfare metric
generation and comparison are applicable across the dis-
order spectrum. This offers opportunities for future
studies to both expand the reported eight disorder com-
parison, or to objectively assess, compare and suggest
priorities within other disorder groups.
Disorders assessed
Breed-related disorders given highest media exposure or
cited as particularly concerning by expert panels on
pedigree dog health are often those perceived as espe-
cially severe for affected individuals within certain
high-risk breed groups [8, 32]. Some of these issues have
extreme animal-level welfare implications, being present
from birth to death, clinically unresolvable and difficult/
impossible to manage through owner education and/or
changes to practice. While important, such disorders
may however be relatively uncommon within dog popu-
lations as a whole and priority should arguably be given
Table 1 All-breed annual period prevalence estimates for eight common disorders of UK dogs with evidence for breed-related status
(Continued)
Disorder
assessed
All-breed annual
period prevalence
estimate (%)
[95% CI]
Breeds with numerical over-representation in disorder case group compared with background
VetCompass population
Breed/type N (of 250
study cases)
Breed-specific annual
period prevalence
estimate (%)
95% CI (%) Prevalence ratio
(Breed-specific
prevalence:All-breed
prevalence)
Boxer 6 6.2 (1.4–11.0) 1.7
Pug 5 6.0 (0.9–11.2) 1.6
Labrador 26 5.1 (3.2–7.0) 1.4
WHWT 9 4.9 (1.8–8.0) 1.4
Cocker Spaniel 12 4.7 (2.1–7.4) 1.3
Springer Spaniel 8 4.6 (1.5–7.8) 1.3
Shih-tzu 10 4.3 (1.7–6.9) 1.2
Osteoarthritis 2.3 [2.1–2.6] Golden retriever 10 7.9 (3.2–12.5) 3.4
Labrador 52 6.7 (4.9–8.4) 2.8
Rottweiler 8 6.4 (2.1–10.7) 2.7
GSD 17 5.8 (3.1–8.5) 2.5
Border collie 10 3.5 (1.4–5.7) 1.5
CKCS 8 3.4 (1.1–5.7) 1.4
Conjunctivitis 2.3 [2.0–2.6] CKCS 17 7.1 (3.8–10.3) 3.1
Labrador 28 3.5 (2.3–4.8) 1.5
WHWT 10 3.5 (1.4–5.7) 1.5
Cocker spaniel 11 2.9 (1.2–4.6) 1.3
Lipoma 1.2 [1.1–1.3] Labrador 47 3.1 (2.2–4.0) 2.6
Springer spaniel 14 2.8 (1.3–4.2) 2.3
Golden retriever 6 2.4 (0.5–4.3) 2.0
Border collie 12 2.2 (1.0–3.4) 1.8
Abbreviations: 95% CI 95% confidence interval, WHWT West Highland White Terrier, KCS King Charles Spaniel, CKCS Cavalier King Charles Spaniel, GSD German
Shepherd dog, JRT Jack Russell terrier
Within disorders breed-specific annual period prevalence estimates are listed for breeds represented by 5 or more individuals in the study group and where estimated
breed-specific prevalence: all-breed prevalence ratios indicated breed over-representation compared with the VetCompass denominator population
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to disorders with the greatest welfare burden across ca-
nine populations.
This study used prevalence estimates generated from
VetCompass data [46] to identify the most common
health issues of welfare impact with any breed associa-
tions, shifting the focus of prioritisation toward issues
with greatest health-related welfare burden across UK
dogs [35, 36]. All eight disorders assessed had sufficient
existing evidence to score at least two on the SEHB scale
[14, 18, 19], supporting likely breed-related as a primary
disorder or secondary to disorders with breed-associations
(e.g. dermatitis secondary to atopy [47]). Despite lower
media profiles and historically poorer research focus [48]
several of these (e.g. bodyweight/obesity and dental disor-
ders) have been highlighted by recent UK surveys as
health and welfare concerns of veterinary surgeons and
other UK canine welfare stakeholders [29, 49–51].
Prevalence
Of the disorders studied, dental disorders (9.6%), over-
weight/obese (5.7%) and anal sac disorders (4.5%) had
the highest prevalence and showed results that were
broadly in line with previous reports [46, 52]. The preva-
lence values reported in the current study were generally
lower than previous estimates that were often based on
referral populations that may have been selectively
biased towards sicker populations. Nonetheless, these es-
timates may also reflect under-reporting of certain con-
ditions such as overweight/obese or osteoarthritis by
primary-care veterinarians as well as differences in case
definition between this and other studies [42, 46]. As ap-
plied here, prevalence represented a reproducible and
comparable metric providing an annual ‘snapshot’ of
relative disorder frequency across the study population
as a whole and within breed groups. Whilst the absolute
frequencies may be underestimates, the relative order of
conditions was likely to be a reliable indicator of their
relative disease burden. Building on previous disorder-
specific work on data from VetCompass, it provided a
systematic basis for disorder groupings which could real-
istically be investigated using these large-scale, primary
care EHR datasets [46].
Duration
Duration of individual health problems is increasingly
emphasised by animal welfare scientists as a key con-
tributor to the overall welfare impact, as recognised in
human medicine [23]. Disorders affecting dogs for ex-
tended periods pose greater risk of cumulative or life-
long pain and other welfare issues, even where daily
levels of discomfort/pain, debilitation or distress appear
relatively low. A recent report by Teng et al. proposed
and applied the Welfare-Adjusted Life Year (WALY),
adapted from the human Disability-Adjusted Life Year
(DALY) concept, as a measure of cause-specific welfare
impact on individual dogs [53]. This complex metric
puts strong emphasis on disorder duration as a compo-
nent of overall welfare compromise, taking into account
both time lived with impaired welfare due to a given
cause and years of life lost after premature death from
that cause (with weighting by perceived cause-specific
level of welfare compromise). Application to 10 common
disorders demonstrated that those with the greatest and
least adverse impact on dogs, according to magnitude of
WALY, were atopic dermatitis (WALY 9.73, largely at-
tributable to time lived impaired) and thoracolumbar
intervertebral disc disease (WALY 2.83, mainly com-
prised of years of life lost). It is also worth noting that
the course of many chronic, progressive disorders
involves episodic “steps”, where issues increase to a
threshold which precipitates revisits and additional
intervention. Recognising and promoting better manage-
ment of chronic conditions at these times provides op-
portunities to significantly reduce welfare burdens
associated with chronic disease that may have been his-
torically underestimated [54].
Based on the median age at earliest disorder-associated
record, dermatitis, anal sac disorders and conjunctivitis
appeared to affect a relatively younger demographic than
osteoarthritis and lipoma. Although late-onset (geriatric)
health issues are often cited as of particular concern
[55, 56], it could also be argued that chronic or pro-
gressive disorders routinely affecting dogs from an
early age constitute a greater priority concern due to
their potentially lifelong welfare effects.
Osteoarthritis, dental disorder, lipoma and overweight/
obese had median annual duration estimates that
exceeded 50, 60, 70 and 80% respectively with over a
quarter of cases affected for the entire annual period. In
contrast, otitis externa, dermatitis, anal sac disorder,
conjunctivitis had much lower median durations (< 4%).
In the latter group of conditions, the number of episodes
per case could generally be more reliably determined
than individual episode durations. Ambiguous or absent
revisit data introduced degrees of uncertainty and sub-
jective interpretation when time delimiting distinct epi-
sodes, with median duration often based on only small
numbers of episodes. Even where feasible episode ‘start’
and ‘end’ dates were available, these likely underesti-
mated true duration as disorders were likely clinically
present before the diagnostic visit. In addition, the me-
dian duration metric itself potentially underestimated
the longer term, cumulative importance of seasonally re-
curring episodic disorders. Annual recurrence patterns
seen in seasonally triggered allergic skin disorders can
manifest as a single, annual ‘flare up’ of dermatitis, otitis
externa, conjunctivitis and/or anal sac irritation [47, 57].
This single, seasonal episode per study year generates a
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low median duration which may not properly reflect cu-
mulative lifetime welfare burden for affected individuals.
In the context of the present retrospective study design
and data, it was not possible to completely address these
limitations. However, median duration could theoretic-
ally be assessed with greater accuracy within prospective
clinical studies, gathering reliable episode duration
through planned progress assessments and welfare im-
pact metrics could be generated using longer defined
study periods to explore potential limitations for season-
ally linked or infrequently recurrent disorders.
Objective and quantitative methods are required to
compare duration across the spectrum of canine disease.
The current study estimated the annual duration for
each disorder but given that this was across a sample of
250 cases, it also reflected the varying age structures of
these cases. Annual disorder duration could also be use-
ful to estimate the lifetime duration for each disorder al-
though this remains challenging until large-scale
birth-to-death health data on dogs become available. In
the meantime, the novel median duration metric devel-
oped in the current study offers a reproducible, compar-
able alternative to true lifetime duration measures (or
WALYs), by restricting retrospective review of EHR data
to a single study year and using information typically re-
corded in these datasets across a wide spectrum of
disorders.
Severity
Overall severity scores were highest for osteoarthritis
(score 13), otitis externa [11] and dermatitis [10]. Over
50% of osteoarthritis cases presented primarily for the
condition at least once, over 50% received over 14 con-
secutive days of analgesic/anti-inflammatory therapy and
over 3% were referred for osteoarthritis management in
the study year. This suggests that osteoarthritis is recog-
nised and perceived by both veterinary surgeons and
owners as important enough for significant clinical care,
often involving long term maintenance prescription only
analgesia, multiple additional medical interventions, fre-
quent clinic visits and relatively high levels of referral
uptake. Severity scores were marginally lower but
showed similar patterns in otitis externa and dermatitis.
However, the particularly high sub-score assigned to oti-
tis externa for non-analgesic/non-anti-inflammatory
therapy prescribed was influenced by the formulation of
many aural medication products, which typically contain
anti-septic, anti-microbial, anti-fungal and physical
cleansing elements in a single preparation.
Overweight/obese and dental disorders had compara-
tively low overall severity scores (3 and 7), which ap-
pears contradictory to established veterinary consensus
on the critical importance of these issues to health-re-
lated canine welfare [29, 49–51]. Diagnosis was usually
incidental, with few associated veterinary visits and min-
imal interventions received, suggesting that owners may
fail to recognise these problems or are not sufficiently
motivated or concerned to seek veterinary attention or
take up recommended interventions. A 2011 online sur-
vey reported that only 52.3% of owners would present a
pet primarily for halitosis, supporting low owner recogni-
tion or appreciation of the serious clinical consequences
associated with dental disorders [55]. Alternatively,
owners may be unaware of treatment possibilities, uncon-
vinced of the need for dental care/weight loss in their pets
or confused by conflicting advice from different areas of
the pet health care sector. Owner choices may be based
on external and non-veterinary advice, or financial restric-
tions or priorities, particularly if treatment or care is ex-
cluded by pet insurance policies. Some may be unwilling
or unable to invest the time or find recommended
day-to-day interventions like tooth brushing and dietary
restriction difficult to implement [58–60].
Owner uptake (not just veterinary recommendation)
of interventions, re-examination or referral were key
when assigning disorder-specific sub-scores for individ-
ual severity metrics. This helps reflect owner perceptions
of disorder importance but could mask veterinary-per-
ceived severity in disorders where owners frequently de-
clined recommended interventions or failed to return
for follow-up care, perhaps due to lack of concern or
limited resources. As applied here, the severity scoring
system did not consider the welfare consequences of
common secondary conditions or exacerbation of
co-morbidities when assigning severity scores for
assessed disorders. For example, no overweight/obese
cases received directly therapeutic referral, analgesia/
anti-inflammatories or procedures under GA/sedation,
but potentially important detrimental consequences of
sequelae/co-morbidities such as osteoarthritis [61–64]
also remained unaccounted for in cases. Specific
co-morbidity scenarios could theoretically be evaluated
and compared in future studies, providing transparent
case definitions were clearly defined. Overall, compari-
son of sub-scores for the seven severity metrics gave
useful insights into owner-perceived importance of dif-
ferent disorders, by reflecting differential levels of drive
to present affected dogs, take up recommended inter-
ventions and attend for ongoing or specialist care.
Overall welfare impact and suggested priority areas
Dental disorder, osteoarthritis, overweight/obese and lip-
oma ranked highest among the 8 studied disorders based
on VetCompass Welfare Impact scores. Top-ranking
duration and severity scores, interpreted alongside indi-
vidual severity metric sub-scores characterised osteo-
arthritis as a relatively frequent primary reason for
veterinary presentation, with multiple related visits per
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year, frequent association with chronic pain management
and a notable level of associated referral. This evidence
supports osteoarthritis as a priority disorder for targeted
reform [42].
Recent surveys by the British Veterinary Association
(BVA) and Peoples Dispensary for Sick Animals (PDSA)
reported that UK veterinary surgeons consider obesity/
excessive bodyweight [29, 49, 51] and dental disorders
[50] to be the most important health related welfare is-
sues currently affecting UK dogs. Both scored highly for
prevalence and duration, but severity sub-scores ap-
peared to indicate mismatches in veterinarian-owner
perceptions of their individual welfare importance. This
may also highlight dental disorders and overweight/
obese as areas where increasing owner awareness of clin-
ical signs, primary consequences and secondary risks of
associated sequelae could improve health-related welfare
in a significant proportion of UK dogs [65, 66].
Numerical over-representation of individual breeds within
disorder case groups
A number of breeds were numerically over-represented in
every disorder group. Assessing breed over-representation
within a disorder by comparing breed-specific annual
period prevalences with overall period prevalence was
intended to avoid highlighting spurious potential
disorder-associations in generally popular breeds (i.e.
some breeds may present more with dental disorders sim-
ply as a function of their popularity within the population,
but are not numerically over-represented within the ran-
domly selected case group studied). The authors acknow-
ledge that these comparisons were only undertaken for
the most commonly represented breeds in each disorder
(represented by > 5 individuals), thus less likely to flag-up
potential disorder associations in less common breeds.
However it is important to stress that these studies were
based on relatively small samples and were likely under-
powered to identify all true breed associations regardless
of this approach. Exploration of individual breed-disorder
predispositions was not a primary objective of this study
but rather to establish evidence for breed associations in
general, in support of disorders that may have an inherited
element. It remains interesting to note that the majority of
breed-disorder over-representations seen were consist-
ent with previously reported breed-disorder associa-
tions, including otitis externa in Cocker spaniels [67, 68],
osteoarthritis in Labrador and Golden retrievers [69, 70]
and dermatitis in Bulldogs, Boxers, Pugs and German
shepherd dogs [47, 57]. As such the findings of the
present study appear to support existing evidence for
established breed-disorder associations and could dir-
ect future predisposition investigations using larger
sample sizes [71].
Limitations
This study aimed to develop and apply a standardised
methodology for disorder assessment to maximise
comparability of prevalence, duration and severity across
disorders, but individual disorder assessments and com-
parisons remain sensitive to certain ‘critical control
points’. As previously discussed, these include selection
criteria for disorders to be assessed, specificity of case
definitions, inclusion criteria, subjective interpretation of
available clinical free text, availability of all required data
for parameter estimation, criteria for assigning severity
metric sub-scores and methodology for annual duration
estimation. Nonetheless, the primary comparisons aimed
to establish relative measures and scores rather than ab-
solute numerical indices of health-related welfare. Defin-
ing SEHB level 2 in at least one breed as sufficient
evidence to consider a disorder ‘breed-related’ did not
constitute strong evidence for genetic inheritance/hered-
itability. However, in this study the interest was in com-
paring disorders with a tendency for association with
certain breeds for various, not necessarily solely genetic,
reasons. For example, environmental, epigenetic and so-
cioeconomic factors may also be relevant if certain
breeds tend to be owned by less experienced or affluent
dog owners, those whose lifestyle/housing offers fewer
opportunities for exercise, or are inclined to feed their
pets in particular ways. Hence, it was not critical to seek
the higher levels of evidence for genetic inheritance
which remain relatively scarce within the available litera-
ture on canine genetics [14, 18, 19].
Broad diagnostic specificities applied within some dis-
order groupings may fall short of the fine-grained level
achievable in referral or smaller-scale prospective stud-
ies. Some case definitions reflected common approaches
in primary care practice, rather than confirmed diag-
noses, e.g. lipoma diagnosis without pathological sup-
porting evidence or osteoarthritis diagnosis without
radiographic imaging. However, these wider case defi-
nitions better reflect the typically varied level of diag-
nostic certainty available to clinicians in the primary
care setting and allowed researchers to harness the
unique benefits of analytical scale offered by the
VetCompass database.
Using data available within VetCompass in 2013 intro-
duced certain potential limitations to the generalisability
of study findings to all UK primary care practices. The
study included a mix of private and corporate but with a
predominance of corporate practices. This may have
skewed the results towards the standards and policies of
clinical management and care that are typical of these
corporate practices. Additionally, the study represents
the demographic breed structure in dogs in 2013. This
structure of the UK veterinary dog population may
change over time with consequent changes in the
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frequency and nature of the most common disorders.
The age of the dataset could also mean that certain top-
ical/relevant breed-disorder associations change, e.g.
brachycephalic breeds are becoming increasingly popular
in the UK. These breed types have strong, well-docu-
mented disorder associations that would therefore be ex-
pected to elevate the frequency of these disorders in the
overall dog population over time. Future studies analys-
ing more recent VetCompass datasets can provide valu-
able scope to reflect and compare current caseloads
within both private and corporate veterinary settings.
All welfare metric scoring in this study was designed
for disorder (rather than individual) level assessment,
thus could not be used to reflect ranges in severity be-
tween individual cases of the same disorder. The authors
recognise that the range of individual case severity
within-disorder is an important area of research, and
could provide opportunities to examine relative severity
of a disorder between defined sub-groups of affected
dogs (e.g. individual breeds). Appropriate re-framing of
the proposed severity scoring system, or modification of
published severity scoring systems such as the GISID
[14] for practical application to VetCompass EHR data
at individual dog level would expand the scope of future
VetCompass studies to describe welfare impact at both
individual, group and overall disorder levels. It should
also be acknowledged that the current work focused on
health related welfare impacts only and did not attempt
to evaluate other elements of the animals’ welfare. Fur-
ther, though the study identified seven specific metrics
for assessment, it is acknowledged that not all of these
might apply equally to all conditions. As such, the aim
of the study was to offer transparent and consistent se-
verity assessments. By providing the individual metric
scores in addition to their combination, there remains
the scope for those interpreting these scores to focus on
one or more individual metrics, rather than all measures
as deemed appropriate.
Generating an overall welfare impact score by sum-
ming selected indicators of prevalence, severity and dur-
ation may seem to contradict the published concept of
population welfare impact as the product of these
three key concepts [35, 36]. Taking a summative ap-
proach was considered a mathematically valid alterna-
tive, and allowed the inclusion of a zero score within
the severity scoring system (to maintain distinction
between none and few cases contributing data of rele-
vance within individual severity metrics). While differ-
ential weighting of individual contributor factors was
avoided here, a summative approach to welfare
impact scoring still offers scope for mathematical
weighting should future users wish to emphasise the
importance of particular contributing factors on wel-
fare impact score.
On balance, this large-scale epidemiological analysis of
primary-care EHRs provides valuable evidence, comple-
mentary to that from more detailed, smaller scale studies
undertaken prospectively or within referral/specialist
caseloads. Specific controversies over disorder defini-
tions or researcher judgements should not detract from
the applicability of the disorder assessment approach
across a range of conditions. Transparency of case defi-
nitions, data availability and criteria for individual metric
calculation are key to the valid interpretation of findings
from future applications of these methods.
Practical implications
The practical implications of this study are many and
varied. While not aimed directly at pet owners, findings
reported can indirectly raise owner awareness through
veterinary healthcare professionals, providing the latter
with evidence to support care recommendations in pri-
ority areas of welfare concern which are routinely under-
estimated or dismissed by owners as unimportant. We
also present a transferable framework for evidence-based
disorder prioritisation, potentially useful for canine
health and welfare stakeholders with funding to allocate
to particular areas of canine health-related welfare con-
cern. Applied to new (or expanded) lists of potential pri-
ority disorders, this tool could help canine charities,
organisations or research institutions to target available
resources at disorders with greatest population-level wel-
fare impact. Strategic funding of public awareness cam-
paigns, further research or lobbying for improvements
to regulations governing the key areas of concern
highlighted could ultimately raise standards of welfare in
pet dogs across the UK. Results from VetCompass stud-
ies on breed-related disorders are directly contributing
to the ongoing development of breed health strategies
such as those of the Kennel Club’s Breed Health and
Conservation Plans project [72] and the strategic frame-
work aims of the Brachycephalic Working Group [73].
In addition, our research group are actively updating the
accepted welfare constructs of animal welfare scientists
through conferences such as UFAW [74].
Conclusions
Eight of the most common breed-related conditions seen
in dogs attending primary care veterinary practices were
identified for assessment of disorder-specific health-re-
lated welfare impact. Novel assessment tools were devel-
oped and applied to evaluate EHR information from
affected dogs to score and compare health-related wel-
fare impact at a population level. Dental disorders,
osteoarthritis and overweight/obese had highest overall
VetCompass Welfare Impact scores. Severity metric
sub-scores appear to support mismatches between veterin-
ary and owner perceptions of obesity/excessive bodyweight
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and dental disease as significant canine health issues [51],
suggesting benefits from improved owner awareness in
these areas.
This study provides proof-of-concept for the applic-
ability of standardised methods for population-level,
health-related welfare impact assessment across a
spectrum of canine conditions using EHR data. The Vet-
Compass Programme offers substantial practical oppor-
tunities for evidence-based disorder prioritisation
according to sound epidemiological principles [35, 36].
The proposed novel welfare impact assessment offers an
evidence-based alternative to existing, expert opinion-
based scoring methods, reflecting relative welfare bur-
dens at the population-level based on real data. Disorder
comparison via transparent consideration of all con-
tributory metrics leaves scope for subsequent users of
the results to place differential emphasis on individual
contributory factors as desired. The proposed strategy is
directly applicable to a broad range of disorder priori-
tisation scenarios, offering an evidence-based but flexible
decision-making framework for stakeholders keen to
maximise welfare improvement returns from investment
of available resources. The VetCompass Welfare Impact
assessment tools developed here could also be incorpo-
rated into prospective studies, providing unique or com-
plementary perspectives on welfare effect within and
between canine disorders.
Methods
Ethical approval
The project received ethical approval from the RVC Ethics
and Welfare committee (RVC URN 2015 1369).
Source of data
The VetCompass Programme collates de-identified EHR
data from UK primary-care veterinary practices for epi-
demiological research. Collaborating practices can rec-
ord summary diagnosis terms during episodes of care
from an embedded VeNom code list [75]. Data fields
held within the VetCompass database include species,
breed, date of birth, sex, neuter status, insurance status,
bodyweight, clinical information from free-text clinical
notes, any summary diagnosis terms including VeNom
codes recorded, and treatments/interventions sold in as-
sociation with individual animals, all with associated re-
cording dates.
Selection of disorders for welfare impact assessment
Disorders were considered for assessment based on ful-
filment of two criteria:
1) Relatively high disorder frequency in UK dogs.
Disorders with highest estimated prevalence in UK
veterinary-attending pet dogs were identified by
review of previously published VetCompass analyses
[46].
2) Acceptable evidence in the literature to suggest a
disorder may show breed-relatedness, i.e. particular
association with at least one canine breed, rather
than broadly affecting all breeds/types within the
canine population at a similar frequency. The
authors determined that an acceptable level of
evidence to define a disorder as breed-associated
was attainment of a minimum level 2 on the
Strength of Evidence for Hereditary Basis (SEHB)
scale for at least one canine breed/type. SEHB level
2 requires ‘prior evidence of an apparent breed
predisposition based on numerical over-representation/
risk compared to a suitable baseline or reference
population’ upon review of existing literature of
relevance to that disorder [18].
Within the time restraints of this project it was pos-
sible to complete welfare impact assessment studies in
eight of the most prevalent disorders meeting both these
criteria.
Study population
The study population included all dogs under veterinary
care at VetCompass participating clinics between
January 1st and December 31st 2013 (inclusive). Dogs
with a) at least one EHR recorded during 2013 or b)
at least one EHR recorded both before and after 2013
were defined as ‘under veterinary care during 2013’.
An animal was considered to have an EHR if a
VeNom diagnosis term, free-text clinical note, treat-
ment or bodyweight was recorded.
Disorder assessment strategy
Assessment of the welfare impact of each selected dis-
order on the UK dog population was undertaken via
disorder-specific studies of standardised design, using
VetCompass EHR data from 250 randomly selected
cases recorded during 2013. Power calculations to report
the prevalence of individual conditions with a precision
of +/− 2–3% indicated each disorder study required ap-
proximately 200–250 cases per condition (95% confi-
dence level, OpenEpi, Version 3).
A multi-stage approach was used for case selection.
First, dogs in the study population likely to be affected
by the disorder during 2013 were identified as ‘candidate
cases’ (CCs), using keyword searches designed to achieve
good sensitivity and specificity for case capture. Keyword
searches were based on disorder-associated terms (full
or partial words or groups of words) likely to be re-
corded in clinical notes, recorded as VeNom terms or
within parameter fields of relevance to individual disor-
ders (e.g. body condition score). Initial keyword selection
Summers et al. BMC Veterinary Research          (2019) 15:163 Page 13 of 20
was based around disorder-specific literature reviews,
relevant VeNom diagnostic terms and expert opinion
(obtained through consultation with specialist veterinary
practitioners in a field relevant to each disorder). Search
terms were combined into keyword search strategies
which were then trialed, refined and expanded iteratively
using additional terms suggested by natural language
processing (NLP) searches [76]. NLP searches were
based on words commonly occurring in the notes of
sample cases originally identified by certain key disorder
terms. At each stage, combinations of search terms were
evaluated via review of EHR data from a pilot sample of the
potential cases captured until a final set of search terms
was established. Total CCs identified by the final search
strategy and a list of unique identifiers were recorded.
Next, EHR data from a random sample of all CCs
identified was manually reviewed against specified case
definition criteria, to determine a disorder-specific study
groups of 250 verified cases. A sub-group of all CCs
identified by the final keyword search strategy was ran-
domly sampled for potential inclusion. Randomisation
was achieved using the RAND function in Microsoft
Excel (2013) to assign each CC a random identification
(ID) number. The CCs were then sorted by descending
magnitude of ID. Maintaining this order, EHR data from
individual CCs were manually reviewed in detail against
the case definition to verify or reject disorder-affected
status in 2013. For consistency, manual review was
undertaken by an individual researcher, experienced in
reviewing primary care veterinary clinical notes, accord-
ing to protocols developed in consultation with other
VetCompass research team members over a preliminary
study design period. Case definitions for the selected dis-
orders were finalised with reference to published litera-
ture. The main elements consistent across all disorder
case definitions were as follows:
 EHR data must have provided a ‘clear, recorded
diagnosis’ of the relevant disorder; i.e. the diagnosis
must have been recorded in at least one clinical note
from the year 2013 using accepted terms or via
recognisable synonyms, abbreviations, misspellings
or typing errors.
 Where relevant health parameters were embedded
within the clinical records, values acceptable as
directly indicative of disorder were stated (e.g. scores
of 5/10 or above in a Body Condition Score field
were accepted as indicating clinically overweight).
 Notable additional inclusion criteria were specified;
e.g. dogs where 2013 notes indicated a permanent
disorder-associated abnormality originating before
01.01.2013, resulted in the animal being classified as
disorder positive during 2013 according to the
relevant case definition.
 Examples of acceptable disorder-specific recording
terminology and common conventions in note-taking
were specified (e.g. ‘AGs++’, indicated that anal sacs
were excessively full, thus abnormal).
Manual reviewing continued down the list until 250
cases were verified for inclusion in each disorder group.
The case verification rate within the CC sample was cal-
culated based on the number of CCs reviewed to achieve
250 cases (250/total CCs reviewed to verify 250 cases).
Data relevant to assessment of welfare impact and
study group demography were extracted from the EHRs
of all individual cases using both automated and manual
extraction methods. Automated demographic data ex-
traction identified breed (categorised by individual UK
Kennel Club (KC) recognised breed or type, or as gen-
eric ‘Crossbreed’) and dates of birth and death. All
additional clinical data required for welfare metric gen-
eration were extracted via structured manual case review
using a bespoke software application (VetCompass App;
see acknowledgements). Relevant data were extracted
from cases using standardised study questions relating
to severity and duration during EHR review (see mea-
sures described below), then data for each disorder
group were pooled for generation of disorder-level wel-
fare metrics, as described below. Case-finding and data
interrogation were limited to data from 2013 in order to
derive annual prevalence estimates and evaluate disorder
severity and duration based on a consistent time period,
for optimal comparability.
Health related welfare metric generation
Prevalence
Annual period prevalences (i.e. the proportion of the
population affected by each disorder at any point during
the study year) were estimated via a scaling method, as
previously described [77]. The proportion of cases veri-
fied from detailed review of EHR data from the ran-
domly selected subset of CCs was used as a scaling
factor to estimate the expected number of confirmed
cases if all candidate cases had been reviewed. The
prevalence was estimated as the expected number of
cases if all candidate cases had been reviewed divided by
the study VetCompass denominator. Ninety five per cent
confidence intervals for annual period prevalence were
calculated by standard approaches taking into account
the sampling approach [78].
Disorder duration
A number of metrics were defined to reflect different as-
pects of disorder duration across the spectrum of dis-
eases. Duration metrics included: median individual
episode duration (days), median number of episodes per
year, median total annual duration (median % of year
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affected), median age at first disorder presentation or
diagnosis in 2013 and the proportion of each disorder
group affected by the disorder for the full year (%).Met-
rics were generated as appropriate for individual disor-
ders using clinical knowledge of their nature and
patterns of occurrence where recorded in the EHR. Dis-
orders with evidence of at least one start and end date
available in clinical records, within the study period,
were considered ‘episodic’. Disorders considered to be
permanent or continuous, even with therapeutic man-
agement/intervention were considered ‘non-episodic’.
Duration metric calculation was approached separately
for episodic and non-episodic conditions. For episodic
conditions, the median episode duration (episodic disor-
ders) was estimated using durations of all episodes of a
disorder recorded in the EHRs in 2013. A case could
contribute more than one episode to this calculation, or
none if diagnosis and resolution dates were not available
for any episodes. The median number of episodes per
case was calculated directly from the number of episodes
seen in cases in 2013. The median percentage of the year
affected was calculated from the median number of epi-
sodes multiplied by the median episode duration during
2013 (as below). The range for duration was calculated
from the minimum and maximum number of episodes
and their respective durations. Where the upper limit
was calculated as greater than 365 days this was reported
as 100%. The interquartile range was not calculated for
episodic disorders.
Median % of year affected (episodic disorders) = [(median
number of episodes per case*median episode duration)/
365]*100.
Range of % study year affected = (minimum number of
episodes per case during year*minimum episode dur-
ation) to (maximum episodes per case during year*maxi-
mum episode duration).
For non-episodic conditions the median percentage of
2013 affected, was calculated directly from the affected
periods of individual cases. For cases with a start date
prior to 1st January 2013 and no evidence of death dur-
ing the year this was classified as a 100% year duration.
For dogs first diagnosed in 2013 the duration was from
the start date until the end of 2013 or the date of death
if there was evidence the animal died during 2013.
Additional duration metrics calculated (where relevant
to individual disorders) included the proportion of cases
with > 1 episodes per study year (episodic disorders
only), the proportion of cases affected by the disorder
for the entire year and the age at first disorder presenta-
tion or diagnosis in 2013.
Disorder severity
Seven individual severity metrics were defined based on
both their potential to objectively reflect aspects of
veterinarian and/or owner perceived disorder severity
and the types of clinical data commonly recorded in
EHRs (Table 5). The severity measures included the ap-
parent imperative to present dogs with this disorder for
veterinary care (i.e. primary vs partial presenting com-
plaint vs incidental finding), the frequency of disorder-
related primary care visits, disorder-related analgesia and
anti-inflammatory therapy, the range of other (i.e.
non-analgesic/anti-inflammatory) medical therapy used,
the extent of disorder-related surgical procedures per-
formed, presence of overnight primary-care hospitalisa-
tions and evidence of disorder-related referral.
Data relevant to each metric were manually extracted
from the EHRs of all cases using a structured set of
questions, as previously described. Disorder-level sub-
scores on a four-point ordinal scale (0–3, indicating in-
creasing severity level) were assigned at a disorder (not
individual animal) level. These were based on the com-
bined findings within each disorder, to reflect an ‘aver-
age’ severity level for the disorder. A zero score was
assigned only where no cases contributed to a given se-
verity metric (e.g. no cases referred or hospitalised over-
night during 2013). Individual metrics and sub-score
criteria are summarised in Table 5. For each disorder,
sub-scores were reported individually and summed to
generate an overall disorder level severity score (max-
imum 21). This composite scoring approach was adapted
from concepts used in the previously published GISID
severity scoring system [14], modified for scoring at a
disorder (rather than individual) level.
VetCompass welfare impact scoring
Of the welfare metrics explored annual period preva-
lence (%), median proportion of year affected (%) and
disorder overall severity score (maximum 21) were se-
lected as the representative measures of disorder preva-
lence, duration and severity, respectively. Disorder-level
scores for these three metrics were mathematically stan-
dardised and used to generate a novel health-related
VetCompass Welfare Impact (VWI) score, directly com-
parable between disorders. For each disorder, absolute
metric values scores were transformed to index values
(expressed on a scale from 0 to 1) by setting the highest
scoring disorder assessed as the denominator within
each metric. For example the prevalence index value for
a given disorder was the annual period prevalence for
that disorder divided by the annual period prevalence
for the disorder with highest prevalence. This allowed
direct comparison of disorders within each key metric
and ensured equal contribution of each metric to the
disorder-level VWI score. Using the highest scoring dis-
order as the metric baseline provided a baseline relevant
to the specific set of disorders being compared, rather
than using external benchmarks of frequency, duration
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and severity which could distort this comparison.
Disorder-specific prevalence, duration and severity indi-
ces were summed to generate summative VWI scores,
reflecting the population-level welfare impact of each
disorder relative to the others assessed in this study [79].
VWI scores were ranked and tabulated alongside the key
contributing welfare metric values.
Numerical breed-disorder associations
For each disorder, breed–specific annual period preva-
lence (breed-specific prevalence) estimates were also cal-
culated for breeds with ≥5 cases using the breed-specific
expected case numbers and total relevant breed counts
in the VetCompass study population denominator. This
provided key within-breed annual period prevalences
alongside all-breed annual period prevalence for each
disorder. Evidence for potential breed-disorder associa-
tions was generated by comparing breed-specific esti-
mates to overall (all-breed) annual period prevalence
within individual disorders. A breed-specific:all-breed
annual period prevalence ratio > 1 without overlap of
95% confidence intervals was accepted as sufficient evi-
dence for breed predisposition in accordance with the
SEHB scale, Level 2 [18]. Exploration of individual
breed-disorder predispositions was not a primary object-
ive of this study. Rather the assessment technique above
was designed to establish evidence for any apparent
breed links (thus breed-associated status in general) and
to further support existing evidence for an inherited
element in certain disorders.
Statistical analysis
Categorical data used to allocate scores for welfare met-
rics were summarised using numbers of cases (n) and
proportion of study group (%), whilst quantitative data
were assessed graphically for normality and summarised
with median, interquartile range and range, as appropri-
ate [78]. Confidence intervals for proportions reported
were calculated by standard methods [78].
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